Evaluating the implementation and impact of navigator-delivered ePRO home symptom monitoring and management

评估 navigator 提供的 ePRO 家庭症状监测和管理的实施和影响

基本信息

批准号：
10613527
负责人：
Gabrielle Rocque
金额：
$ 61.84万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-05-04 至 2026-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10613527
关键词：
Accident and Emergency department Address Administrator Admission activity Adult Advanced Malignant Neoplasm African American population Alabama Cancer Model Cancer Patient Caring Client satisfaction Clinical Clinical Medicine Collaborations Consolidated Framework for Implementation Research Data Data Sources Distress Economically Deprived Population Effectiveness Electronics Emergency department visit Financial Support Funding Future Goals Health Care Rationing Health Services Research Health system Healthcare Home Hospitalization Hospitals Human Resources Infrastructure Institution Intensive Care Units Intervention Interview Knowledge Letters Maintenance Malignant Neoplasms Malignant neoplasm of lung Measures Medical Care Team Medicare Mental Depression Methodology Minority Mission Modeling Monitor Nurses Nursing Services Oncology Outcome Outcomes Research Patient Care Patient Outcomes Assessments Patient Participation Patients Penetrance Penetration Perception Physicians Population Positioning Attribute Provider Public Health Quality of life Randomized, Controlled Trials Reporting Research Research Personnel Research Support Resources Services Site Surveys Symptoms System Technology Testing Time United States National Institutes of Health Universities Vendor Visit Vulnerable Populations Work adverse outcome cancer care cancer survival cancer therapy chemotherapy cost disability electronic patient reported outcomes evidence base experience functional status health care service utilization hybrid type 2 design implementation evaluation implementation framework implementation intervention implementation outcomes implementation science implementation strategy implementation trial implementation/effectiveness improved innovation intervention delivery patient home care patient navigator patient population payment population based provider adoption randomized trial response rural dwellers scale up socioeconomic disadvantage standard of care success symptom management treatment duration week trial

项目摘要

PROJECT SUMMARY Randomized controlled trials by Basch (collaborator) and colleagues demonstrated that weekly electronic home-based PRO symptom monitoring with automated alerts to clinicians (Home ePRO) in cancer patients was associated with reduced healthcare utilization, improved quality of life, and increased overall survival. However, these trials were administered using infrastructure supported by research funding. A knowledge gap remains about optimal implementation strategies for and effectiveness of Home ePROs in real-world settings. To address this gap, investigators from two institutions will conduct a large-scale, population-based implementation of an evidence-based Home ePRO intervention for all adult cancer patients receiving chemotherapy, including vulnerable populations such as African Americans, rural residents, and socioeconomically disadvantaged individuals. This implementation will leverage infrastructure from Medicare's payment reform projects (Oncology Care Model, Oncology Care First Model), which require and financially support patient navigators, a natural workforce for Home ePRO implementation. Our hypothesis is that the deployed implementation strategies will result in successful navigator-delivered Home ePRO, which will improve both patient and health system outcomes. Using the Consolidated Framework for Implementation Research (CFIR), this hypothesis will be tested using a hybrid type 2 design with three specific aims: 1) evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites; 2) examine the barriers, facilitators, and implementation strategies used in implementing navigator- delivered Home ePRO; and 3) assess the impact of Home ePRO on clinical and utilization outcomes. In Aim 1, Home ePRO will be evaluated using implementation outcomes (service penetrance, provider adoption/penetration, intervention fidelity). In Aim 2, we will gauge patient and healthcare team perceptions of barriers and facilitators of navigator-led Home ePRO, implementation strategies used to address these barriers, implementation strategy fidelity, and perception of implementation strategy ability to address barriers using an iterative qualitative analysis. In Aim 3, patient-level outcomes (functional status, distress, depression, healthcare utilization, cost, survival) will be evaluated using real-world data sources. The project is innovative because it will be the first study to evaluate real-world implementation of navigator-led Home ePRO for all cancer patients receiving chemotherapy, an approach that is both immediately scalable and sustainable within value-based payment models. The proposed research is significant because it is expected to demonstrate successful implementation of navigator-delivered Home ePRO and effectiveness of the ePRO intervention on diverse patient populations. Furthermore, the project will generate an implementation blueprint of successful implementation strategies that can be easily applied to other patient-reported outcomes, with the potential to positively impact patient care as health care transitions to a value-based system.

项目摘要 Basch（合作者）和同事的随机对照试验证明了每周电子癌症患者的临床医生（家庭EPRO）自动警报的家庭症状监测与减少医疗保健利用，改善生活质量以及总体生存率有关。但是，这些试验是使用研究资金支持的基础设施进行管理的。知识差距关于家庭EPRO在现实世界中的最佳实施策略和有效性仍然存在。为了解决这一差距，来自两个机构的调查人员将进行大规模的，基于人口的大规模为所有接受的成年癌症患者实施基于证据的家庭Epro干预化学疗法，包括弱势群体，例如非洲裔美国人，农村居民和社会经济上处于弱势群体的个人。该实施将利用Medicare的基础设施支付改革项目（肿瘤护理模型，肿瘤学护理第一模型），这需要和财务支持患者导航员，这是一个自然劳动力，用于家庭epro实施。我们的假设是部署的实施策略将导致成功交付的Navigator Home Epro，这将改善患者和卫生系统的结果。使用合并框架进行实施研究（CFIR），该假设将使用具有三个特定目的的混合类型2设计进行检验：1）评估在多种练习中，所有癌症患者的导航器分配家庭EPRO的实施站点； 2）检查用于实施导航器的障碍，促进者和实施策略 - 送回家epro； 3）评估家庭epro对临床和利用结果的影响。在AIM 1中，将使用实施成果（服务渗透率，提供商）评估Home Epro 采用/渗透，干预保真度）。在AIM 2中，我们将衡量患者和医疗团队对导航员主导的EPRO的障碍和促进者，用于解决这些策略的实施策略障碍，实施策略保真度以及对实施策略的看法解决障碍使用迭代定性分析。在AIM 3中，患者级别的结果（功能状态，遇险，抑郁，将使用现实世界数据源评估医疗保健利用，成本，生存）。该项目是创新的因为这将是第一个评估所有人的现实世界实施的研究接受化学疗法的癌症患者，这种方法既可以立即可扩展又可持续基于价值的付款模型。拟议的研究很重要，因为它有望证明成功实施导航器授予的家庭epro和Epro干预的有效性多样化的患者人群。此外，该项目将产生成功的实施蓝图实施策略可以轻松应用于其他患者报告的结果，并有可能随着医疗保健向基于价值的系统的过渡，对患者护理的积极影响。